This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.
Novartis and BDI announce partnership
April 05, 2019
Novartis and the University of Oxford’s Big Data Institute to establish world-leading research alliance using artificial intelligence to understand complex diseases and improve drug development
Jan 18, 2019
Unique five-year alliance established between industry and academia to advance the analysis and interpretation of ultra large and multiple datasets, using cutting edge technology including artificial intelligence machine learning
These technologies have the ability to spot disease patterns and signals much earlier in their manifestation, translating more quickly into methods that will support clinical decision making
The alliance will be transformative for how Novartis adopts data science at scale from multiple data sources, beginning with flagship programs in multiple sclerosis, dermatology and rheumatology
